Prognostic impact of polymorphisms in the CASPASE genes on survival of patients with colorectal cancer

Cancer Research and Treatment

Volumn 44, Issue 1, 2012, Pages 32-36

  Choi, Jun Young ^a   Kim, Jong Gwang ^a   Lee, You Jin ^a   Chae, Yee Soo ^a   Sohn, Sang Kyun ^a   Moon, Joon Ho ^a   Kang, Byung Woog ^a   Jung, Min Kyu ^a   Jeon, Seong Woo ^a   Park, Jun Seok ^a   Choi, Gyu Seog ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Caspases; Colorectal neoplasms; Genetic polymorphism; Prognosis

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CASPASE; CASPASE 10; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; DOXIFLURIDINE; FLUOROURACIL; FOLINIC ACID; GENOMIC DNA; OXALIPLATIN;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL;

EID: 84866919571     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2012.44.1.32     Document Type: Article

References (24)

1. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23:609-18.
2. Reed JC. Mechanisms of apoptosis. Am J Pathol. 2000;157:1415-30.
3. Nagata S. Apoptosis by death factor. Cell. 1997;88:355-65.
4. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000;21:485-95.
5. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342-8.
6. Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF. Apoptosis and lung cancer: a review. J Cell Biochem. 2003;88:885-98.
7. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci. 1997;22:299-306.
8. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 1999;15:269-90.
9. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003;22:8543-67.
10. Fuentes-Prior P, Salvesen GS. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J. 2004;384(Pt 2):201-32.
11. Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet. 2007;39:605-13.
12. Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, et al. Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet. 2006;15:1963-71.
13. Jang JS, Kim KM, Choi JE, Cha SI, Kim CH, Lee WK, et al. Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk. Mol Carcinog. 2008;47:383-90.
14. MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, Pharoah PD, et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst. 2004;96:1866-9.
15. Li C, Zhao H, Hu Z, Liu Z, Wang LE, Gershenwald JE, et al. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum Mutat. 2008;29:1443-51.
16. Frank B, Hemminki K, Wappenschmidt B, Meindl A, Klaes R, Schmutzler RK, et al. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis. 2006;27:606-9.
17. Yoo SS, Choi JE, Lee WK, Choi YY, Kam S, Kim MJ, et al. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer. J Clin Oncol. 2009;27:5823-9.
18. Hamilton SR, Aaltonen LA. World Health Oorganization classification of tumors. Pathology and genetics: tumours of the digestive system. Lyon: IARC Press; 2000
19. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002.
20. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, et al. FASTSNP: an always up-todate and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 2006;34(Web Server issue):W635-41.
21. Son JW, Kang HK, Chae MH, Choi JE, Park JM, Lee WK, et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet. 2006;169:121-7.
22. Liu B, Zhang Y, Jin M, Ni Q, Liang X, Ma X, et al. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog. 2010;49:75-84.
23. Kim JG, Chae YS, Sohn SK, Moon JH, Ryoo HM, Bae SH, et al. Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin. Cancer Chemother Pharmacol. 2009;64:953-60.
24. Chae YS, Kim JG, Sohn SK, Lee SJ, Kang BW, Moon JH, et al. RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection. J Cancer Res Clin Oncol. 2011;137:705-13.